Everyone’s favorite bracket challenge has returned. That’s right—it’s time once again for Fierce Pharma Marketing’s annual ...
As patients and healthcare professionals alike increasingly turn to artificial intelligence tools like OpenAI’s ChatGPT and Google’s Gemini rather than traditional search engines for online research, ...
As AI reshapes search and advertising, the question is not whether pharma should be in the AI conversation, but whether we are prepared to participate responsibly.
The state of pharma’s chief marketing officers part 2: Being an ‘innovation catalyst’ for creativity
In the not too distant past, pharma lagged behind consumer advertising’s ability to churn out cutting-edge creativity. Weighed down by the regulatory, safety and compliance aspects that are par for ...
Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging of the population, the increased prevalence of chronic disease and the growing ...
A bill introduced in the Maryland legislature would require drugmakers to disclose ties to disease awareness campaigns.
The lines separating the wellness industry from the healthcare industry continue to blur. At any given pharmacy, over-the-counter medicines, vitamins, skincare, and the next hot homeopathic remedy ...
One advantage we believe we bring to customers is that our platform is end-to-end, it’s wholistic and complete. It reflects the full, tried-and-true pharmaceutical marketing workflow that has been ...
Doximity is experiencing strong user engagement growth, driven by demand from medical prescribers and pharmaceutical marketers. Pharma marketing, Doximity's largest opportunity, is fueling sustained ...
Morning Hubsters. John R Fischer here with the US Wire from the New York newsroom. Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging of ...
Pharmaceutical marketing is undergoing a hard reset. Tougher transparency rules, louder scrutiny of D2C ads, and political pressure on GLP-1s, telehealth, and drug pricing are all hitting at once. The ...
If only 13% of consumers strongly believe brands provide accurate information, how do pharma companies connect with increasingly discerning patients and healthcare professionals? That’s a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results